← Every company
TuHURA Biosciences Inc SEC Filings
What TuHURA Biosciences Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
HURA overview →Filings on file
182
since Oct 7, 2016
Warning signs
18
latest Jan 30, 2026
Last results
Aug 14, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Jun 30, 2025 | Acquisition or sale completed 8-K | Read ↗ |
| Feb 7, 2025 | Merger vote or registration S-4 | Read ↗ |
| Nov 14, 2024 | Acquisition or sale completed 8-K/A | Read ↗ |
| Oct 21, 2024 | Executive or director changeResults announcedAcquisition or sale completedChange in controlMaterial agreement 8-K | Read ↗ |
| May 13, 2024 | Merger vote or registration S-4 | Read ↗ |
| Aug 21, 2020 | Delisting notice or listing transferExecutive or director changeAcquisition or sale completedMaterial agreementUnregistered share sale 8-K | Read ↗ |
| Jun 16, 2020 | Merger vote or registration S-4 | Read ↗ |
Source: TuHURA Biosciences Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.